인증 보도자료
-
- Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States
- Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Comple...
- 07월 01일 14:15
-
- FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products
- Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders g...
- 07월 01일 10:34
-
- DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the ...
- 06월 29일 09:34
